Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
BMJ Open
|
June 24, 2018
Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J'xactly) study
Yasuo Okumura, Ikuo Fukuda, Mashio Nakamura, et al.
Circulation Reports
|
April 7, 2023
Duration of Initial Intensive Rivaroxaban Therapy for Patients With Venous Thromboembolism - Subanalysis of the J'xactly Study
Mashio Nakamura, Ikuo Fukuda, Norikazu Yamada, et al.
Annals of Vascular Diseases
|
October 2, 2023
Prognostication of Patients with Pulmonary Thromboembolism with and without Residual Deep Vein Thrombosis: A Subanalysis of the J'xactly Study
Norikazu Yamada, Ikuo Fukuda, Mashio Nakamura, et al.
Scientific Reports
|
November 27, 2014
Nanoclusters synthesized by synchrotron radiolysis in concert with wet chemistry
Hiroyuki Oyanagi, Yuuichi Orimoto, Kuniko Hayakawa, et al.
Circulation Reports
|
August 29, 2022
Clinical Outcome After Discontinuation of Anticoagulation Therapy in Japanese Patients With Venous Thromboembolism - Insights From the J'xactly Study
Takeshi Yamashita, Ikuo Fukuda, Mashio Nakamura, et al.
Phlebology
|
November 26, 2022
Effectiveness and safety of the direct oral anticoagulant in acute distal deep vein thrombosis: From the prospective multicenter observational study, J'xactly, in Japan
Makoto Mo, Ikuo Fukuda, Mashio Nakamura, et al.
Journal of Cardiology
|
November 18, 2022
Effectiveness and safety of rivaroxaban in patients with venous thromboembolism and active cancer: A subanalysis of the J'xactly study
Shinji Hisatake, Takanori Ikeda, Ikuo Fukuda, et al.
Protein and Peptide Letters
|
April 8, 2003
Synthesis of chemotactic peptide analogs with a photoaffinity cross-linker as new probes for analysis of receptor-ligand interaction
Mitsukuni Shibue, Masahiro Yoshiki, Masaya Miyazaki, et al.
Circulation Reports
|
October 28, 2022
Rivaroxaban Treatment for Patients With Unprovoked or Provoked Venous Thromboembolism - Subanalysis of the J'xactly Study
Shinji Hisatake, Takanori Ikeda, Ikuo Fukuda, et al.
Thrombosis Journal
|
August 20, 2023
Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J'xactly study
Shohei Migita, Yasuo Okumura, Ikuo Fukuda, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
BMJ Open
|
June 24, 2018
Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J'xactly) study
Yasuo Okumura, Ikuo Fukuda, Mashio Nakamura, et al.
Circulation Reports
|
April 7, 2023
Duration of Initial Intensive Rivaroxaban Therapy for Patients With Venous Thromboembolism - Subanalysis of the J'xactly Study
Mashio Nakamura, Ikuo Fukuda, Norikazu Yamada, et al.
Annals of Vascular Diseases
|
October 2, 2023
Prognostication of Patients with Pulmonary Thromboembolism with and without Residual Deep Vein Thrombosis: A Subanalysis of the J'xactly Study
Norikazu Yamada, Ikuo Fukuda, Mashio Nakamura, et al.
Scientific Reports
|
November 27, 2014
Nanoclusters synthesized by synchrotron radiolysis in concert with wet chemistry
Hiroyuki Oyanagi, Yuuichi Orimoto, Kuniko Hayakawa, et al.
Circulation Reports
|
August 29, 2022
Clinical Outcome After Discontinuation of Anticoagulation Therapy in Japanese Patients With Venous Thromboembolism - Insights From the J'xactly Study
Takeshi Yamashita, Ikuo Fukuda, Mashio Nakamura, et al.
Phlebology
|
November 26, 2022
Effectiveness and safety of the direct oral anticoagulant in acute distal deep vein thrombosis: From the prospective multicenter observational study, J'xactly, in Japan
Makoto Mo, Ikuo Fukuda, Mashio Nakamura, et al.
Journal of Cardiology
|
November 18, 2022
Effectiveness and safety of rivaroxaban in patients with venous thromboembolism and active cancer: A subanalysis of the J'xactly study
Shinji Hisatake, Takanori Ikeda, Ikuo Fukuda, et al.
Protein and Peptide Letters
|
April 8, 2003
Synthesis of chemotactic peptide analogs with a photoaffinity cross-linker as new probes for analysis of receptor-ligand interaction
Mitsukuni Shibue, Masahiro Yoshiki, Masaya Miyazaki, et al.
Circulation Reports
|
October 28, 2022
Rivaroxaban Treatment for Patients With Unprovoked or Provoked Venous Thromboembolism - Subanalysis of the J'xactly Study
Shinji Hisatake, Takanori Ikeda, Ikuo Fukuda, et al.
Thrombosis Journal
|
August 20, 2023
Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J'xactly study
Shohei Migita, Yasuo Okumura, Ikuo Fukuda, et al.
Page
of 9